[Nephron sparing in the management of localized solid renal mass].

[1]  O. Hélénon,et al.  [Cancer imaging and prevention of renal failure]. , 2022, Bulletin du Cancer.

[2]  J. Bernhard,et al.  French AFU Cancer Committee Guidelines - Update 2022-2024: management of kidney cancer. , 2022, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[3]  O. Hélénon,et al.  Percutaneous Thermal Ablation for Renal Tumors in Patients with Birt–Hogg–Dubé Syndrome , 2022, Cancers.

[4]  M. Ferro,et al.  Quality of Life and Psychological Distress among Patients with Small Renal Masses , 2022, Journal of clinical medicine.

[5]  S. Hancock,et al.  Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. , 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

[6]  J. Correas,et al.  Disease Progression in Older Patients With Renal Tumor Assigned to an Active Surveillance Protocol. , 2021, Clinical genitourinary cancer.

[7]  J. Cadeddu,et al.  Radiofrequency Ablation of Small Renal Masses. , 2021, Journal of endourology.

[8]  R. Clayman,et al.  Can preoperative renal mass biopsy change clinical practice and reduce surgical intervention for small renal masses? , 2021, Urologic oncology.

[9]  B. Lane,et al.  Utilization of Renal Mass Biopsy for T1 Renal Lesions across Michigan: Results from MUSIC-KIDNEY, A Statewide Quality Improvement Collaborative , 2021, European urology open science.

[10]  Sam S. Chang,et al.  Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-up: AUA Guideline: Part II. , 2021, The Journal of urology.

[11]  Sam S. Chang,et al.  Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline: Part I , 2021, The Journal of urology.

[12]  K. Bensalah,et al.  Percutaneous Ablation Versus Surgical Resection for Local Recurrence Following Partial Nephrectomy for Renal Cell Cancer: A Propensity Score Analysis (REPART Study-UroCCR 71). , 2021, European urology focus.

[13]  Laurentiu M. Pop,et al.  Neoadjuvant SAbR for Renal Cell Carcinoma Inferior Vena Cava Tumor Thrombus - Safety Lead-in Results of a Phase II Trial. , 2021, International journal of radiation oncology, biology, physics.

[14]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[15]  A. Jemal,et al.  Cancer Statistics, 2021 , 2021, CA: a cancer journal for clinicians.

[16]  P. Pierorazio,et al.  Outcomes of Active Surveillance for Young Patients with Small Renal Masses: Prospective Data from the DISSRM Registry. , 2020, The Journal of urology.

[17]  K. Bensalah,et al.  [French ccAFU guidelines - update 2020-2022: management of kidney cancer]. , 2020, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[18]  X. Cathelineau,et al.  Renal Tumor Biopsy: Rationale to Avoid Surgery in Small Renal Masses , 2020, Current Urology Reports.

[19]  K. Bensalah,et al.  Limitations of Available Studies Prevent Reliable Comparison Between Tumour Ablation and Partial Nephrectomy for Patients with Localised Renal Masses: A Systematic Review from the European Association of Urology Renal Cell Cancer Guideline Panel. , 2020, European urology oncology.

[20]  K. Bensalah,et al.  What Is Better for Predicting Morbidity of Robotic Partial Nephrectomy-A Score or Your Clinical Judgement? , 2020, European urology focus.

[21]  A. Levey,et al.  Chronic Kidney Disease and Kidney Cancer Surgery: New Perspectives. , 2020, The Journal of urology.

[22]  M. Nielsen,et al.  Management of small renal masses in patients with chronic kidney disease: Perspectives from a nephrologist. , 2019, Urologic oncology.

[23]  H. Cathro,et al.  Does renal mass biopsy influence multidisciplinary treatment recommendations? , 2019, Scandinavian journal of urology.

[24]  I. Kaplan,et al.  Stereotactic Ablative Radiotherapy for ≥T1b Primary Renal Cell Carcinoma: A Report from the International Radiosurgery Oncology Consortium for Kidney (IROCK). , 2019, International journal of radiation oncology, biology, physics.

[25]  J. Cheville,et al.  Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses. , 2019, European urology.

[26]  S. Kanazawa,et al.  Percutaneous thermal ablation for renal cell carcinoma in patients with Birt-Hogg-Dubé syndrome. , 2019, Diagnostic and interventional imaging.

[27]  I. Wu,et al.  Higher risk of malignant neoplasms in young adults with end‐stage renal disease receiving haemodialysis: A nationwide population‐based study , 2019, Nephrology.

[28]  F. Bray,et al.  Epidemiology of Renal Cell Carcinoma. , 2019, European urology.

[29]  S. Pal,et al.  Distress in patients with renal cell carcinoma: a curious gap in knowledge , 2018, BJU international.

[30]  V. Khoo,et al.  TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II , 2018, BMC Cancer.

[31]  J. Kaouk,et al.  The Role of Ablation and Minimally Invasive Techniques in the Management of Small Renal Masses. , 2018, European urology oncology.

[32]  G. Rücker,et al.  Partial nephrectomy versus ablative techniques for small renal masses: a systematic review and network meta-analysis , 2018, European Radiology.

[33]  C. Wood,et al.  Conditional survival of patients with small renal masses undergoing active surveillance , 2018, BJU international.

[34]  B. Trock,et al.  Comparative effectiveness of management options for patients with small renal masses: a prospective cohort study , 2018, BJU international.

[35]  Coral L. Atoria,et al.  Percutaneous Ablation Versus Partial and Radical Nephrectomy for T1a Renal Cancer , 2018, Annals of Internal Medicine.

[36]  Kathryn J Fowler,et al.  Quantitative multiparametric MR analysis of small renal lesions: correlation with surgical pathology , 2018, Abdominal radiology.

[37]  C. Dietrich,et al.  The EFSUMB Guidelines and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound (CEUS) in Non-Hepatic Applications: Update 2017 (Long Version) , 2018, Ultraschall in der Medizin - European Journal of Ultrasound.

[38]  I. Kaplan,et al.  Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the International Radiosurgery Oncology Consortium for Kidney (IROCK) , 2018, Cancer.

[39]  O. Hakenberg,et al.  Analysis of psychosocial stress factors in patients with renal cancer , 2018, Therapeutic advances in urology.

[40]  P. Tamboli,et al.  Local Tumor Bed Recurrence Following Partial Nephrectomy in Patients with Small Renal Masses , 2018, The Journal of urology.

[41]  E. Bass,et al.  Renal Functional Outcomes after Surgery, Ablation, and Active Surveillance of Localized Renal Tumors: A Systematic Review and Meta-Analysis. , 2017, Clinical journal of the American Society of Nephrology : CJASN.

[42]  Anurag K. Singh,et al.  A Pilot Study of Stereotactic Body Radiation Therapy Combined with Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma , 2017, Clinical Cancer Research.

[43]  F. Cornelis,et al.  The future of percutaneous renal ablation. , 2017, Diagnostic and interventional imaging.

[44]  A. Finelli,et al.  Safety, reliability and accuracy of small renal tumour biopsies: results from a multi‐institution registry , 2017, BJU international.

[45]  Charles Swanton,et al.  Renal cell carcinoma , 2017, Nature Reviews Disease Primers.

[46]  F. Orsi,et al.  CIRSE Guidelines on Percutaneous Ablation of Small Renal Cell Carcinoma , 2017, CardioVascular and Interventional Radiology.

[47]  A. Evans,et al.  Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  David C. Miller,et al.  Predictors of Delayed Intervention for Patients on Active Surveillance for Small Renal Masses: Does Renal Mass Biopsy Influence Our Decision? , 2016, Urology.

[49]  B. Trock,et al.  A Prospective, Comparative Study of Quality of Life among Patients with Small Renal Masses Choosing Active Surveillance and Primary Intervention. , 2016, The Journal of urology.

[50]  Konstantinos Katsanos,et al.  Percutaneous Radiofrequency Ablation Versus Robotic-Assisted Partial Nephrectomy for the Treatment of Small Renal Cell Carcinoma , 2016, CardioVascular and Interventional Radiology.

[51]  D. Serie,et al.  Mayo Adhesive Probability Score Is Associated With Localized Renal Cell Carcinoma Progression-free Survival. , 2016, Urology.

[52]  A. Evans,et al.  Renal Tumor Biopsy for Small Renal Masses: A Single-center 13-year Experience. , 2015, European urology.

[53]  Mark W. Ball,et al.  Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry. , 2015, European urology.

[54]  U. Capitanio,et al.  Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a-T1b renal mass and normal preoperative renal function. , 2015, European urology.

[55]  J. Cheville,et al.  Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. , 2015, European urology.

[56]  E. Jonasch,et al.  Psychological states, serum markers and survival: associations and predictors of survival in patients with renal cell carcinoma , 2015, Journal of Behavioral Medicine.

[57]  T. Vogl,et al.  Image-guided tumor ablation: standardization of terminology and reporting criteria--a 10-year update. , 2014, Radiology.

[58]  L. Kuller,et al.  Hypertension and Obesity and the Risk of Kidney Cancer in 2 Large Cohorts of US Men and Women , 2014, Hypertension.

[59]  E. Messing,et al.  Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904. , 2014, European urology.

[60]  K. Katsanos,et al.  Systematic Review and Meta-Analysis of Thermal Ablation Versus Surgical Nephrectomy for Small Renal Tumours , 2014, CardioVascular and Interventional Radiology.

[61]  S. Bhayani,et al.  Percutaneous cryoablation of renal masses: Washington University experience of treating 129 tumours , 2013, BJU international.

[62]  Md. Shad Akhtar,et al.  Active surveillance of small renal masses offers short‐term oncological efficacy equivalent to radical and partial nephrectomy , 2012, BJU international.

[63]  R. Uzzo,et al.  Objective measures of renal mass anatomic complexity predict rates of major complications following partial nephrectomy. , 2011, European urology.

[64]  A. Evans,et al.  Active surveillance of small renal masses: progression patterns of early stage kidney cancer. , 2011, European urology.

[65]  K. Bensalah,et al.  Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery. , 2010, European urology.

[66]  Robert G Uzzo,et al.  The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. , 2009, The Journal of urology.

[67]  O. Hes,et al.  Tumours in end-stage kidney. , 2008, Transplantation proceedings.

[68]  M. Cooperberg,et al.  Renal cell cancer stage migration , 2008, Cancer.

[69]  G Scott Gazelle,et al.  Radiofrequency ablation versus nephron-sparing surgery for small unilateral renal cell carcinoma: cost-effectiveness analysis. , 2008, Radiology.

[70]  K. Bensalah,et al.  Predictive factors for ipsilateral recurrence after nephron-sparing surgery in renal cell carcinoma. , 2008, European urology.

[71]  M. Schonlau,et al.  Renal and cardiovascular morbidity after partial or radical nephrectomy , 2008, Cancer.

[72]  I. Gill,et al.  The evolving presentation of renal carcinoma in the United States: trends from the Surveillance, Epidemiology, and End Results program. , 2006, The Journal of urology.

[73]  Andrew J Vickers,et al.  Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. , 2006, The Lancet. Oncology.

[74]  F. Kondylis,et al.  The natural history of incidentally detected small renal masses , 2004, Cancer.

[75]  M. Pearle,et al.  Laparoscopic interstitial laser coagulation of renal tissue with and without hilar occlusion in the porcine model. , 2002, Journal of endourology.

[76]  M Jayson,et al.  Increased incidence of serendipitously discovered renal cell carcinoma. , 1998, Urology.

[77]  M. A. Lotfi,et al.  Laparoscopic interstitial contact laser ablation of renal lesions: an experimental model. , 1994, Journal of endourology.

[78]  C. Porta,et al.  Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

[79]  P. Pierorazio,et al.  Use of delayed intervention for small renal masses initially managed with active surveillance. , 2019, Urologic oncology.

[80]  P. Pierorazio,et al.  Renal Mass Biopsy is Associated with Reduction in Surgery for Early-Stage Kidney Cancer. , 2019, Urology.

[81]  K. Bensalah,et al.  [CCAFU french national guidelines 2016-2018 on renal cancer]. , 2013, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.